entertainment -WSS

entertainment

author：entertainment 2025-09-06 03:28:07 - browse：22

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Lindsay Lohan welcomes 1st child with husband Bader Shammas

explore

WSS

Medical experts are missing from AI regulatory conversations

HPV vaccine, cervical cancer study delivers historic results

Update the Apgar Score to remove skin color

HPV vaccine, cervical cancer study delivers historic results

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

knowledge

entertainment

hotspot

Activists slam private health insurers over coverage restrictions

To bolster infectious disease surveillance, genomics powerhouses team up

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How dance can help health care workers heal from trauma

What does generative AI mean for health care? We asked experts

Resistance to cancer drugs: A new genetic explanation

New air purifier tech could be key to improving indoor air quality

Maisha Meds is a PBM, but don't call it that

DIEP, the 'gold standard' of breast reconstruction, is under threat

HPV vaccine, cervical cancer study delivers historic results

hotspot

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Man who had jail sentence commuted by Trump arrested again

India sets sights on home

HPV vaccine, cervical cancer study delivers historic results

Lindsay Lohan welcomes 1st child with husband Bader Shammas

entertainment

hotspot

explore

entertainment